These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2576057)

  • 1. The systemic availability of buprenorphine administered by nasal spray.
    Eriksen J; Jensen NH; Kamp-Jensen M; Bjarnø H; Friis P; Brewster D
    J Pharm Pharmacol; 1989 Nov; 41(11):803-5. PubMed ID: 2576057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal bioavailability of buprenorphine in rabbit correlated to sheep and man.
    Lindhardt K; Bagger M; Andreasen KH; Bechgaard E
    Int J Pharm; 2001 Apr; 217(1-2):121-6. PubMed ID: 11292548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers.
    Bai SA; Xiang Q; Finn A
    Clin Ther; 2016 Feb; 38(2):358-69. PubMed ID: 26804639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal absorption of buprenorphine--in vivo bioavailability study in sheep.
    Lindhardt K; Ravn C; Gizurarson S; Bechgaard E
    Int J Pharm; 2000 Sep; 205(1-2):159-63. PubMed ID: 11000552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs.
    Enomoto H; Love L; Madsen M; Wallace A; Messenger KM
    J Vet Pharmacol Ther; 2022 Jul; 45(4):358-365. PubMed ID: 35445748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
    Daley-Yates PT; Baker RC
    Br J Clin Pharmacol; 2001 Jan; 51(1):103-5. PubMed ID: 11167672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of nafarelin in healthy volunteers.
    Chaplin MD
    Am J Obstet Gynecol; 1992 Feb; 166(2):762-5. PubMed ID: 1531580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of intranasal formulations of dihydroergotamine.
    van der Kuy PH; Lohman JJ; Hooymans PM; Ter Berg JW; Merkus FW
    Eur J Clin Pharmacol; 1999 Nov; 55(9):677-80. PubMed ID: 10638398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic bioavailability of nasally applied chlorphenamine maleate (0.4% nasal spray) relative to tablets administered perorally.
    Van Toor BS; Buchwald A; Stengele E; Trenk D; Gercek C; de Mey CM
    Int J Clin Pharmacol Ther; 2001 Apr; 39(4):173-8. PubMed ID: 11332874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasally-administered progesterone: comparison of ointment and spray formulations.
    Cicinelli E; Ragno G; Cagnazzo I; Fanelli F; Vetuschi C; Cantatore FP
    Maturitas; 1991 Oct; 13(4):313-7. PubMed ID: 1775083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline.
    Nau J; Wyatt DJ; Rollema H; Crean CS
    Clin Ther; 2021 Sep; 43(9):1595-1607. PubMed ID: 34456060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of clonazepam after intranasal and buccal administration.
    Schols-Hendriks MW; Lohman JJ; Janknegt R; Korten JJ; Merkus FW; Hooymans PM
    Br J Clin Pharmacol; 1995 Apr; 39(4):449-51. PubMed ID: 7640154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
    Nave R; Herzog R; Laurent A; Wingertzahn MA
    Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients.
    Scaglione F; Scanni A; Tomirotti M; Dimaiuta M; Ferrari P; Fraschini F
    Arzneimittelforschung; 1993 Sep; 43(9):986-8. PubMed ID: 8240464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.
    Thorsson L; Borgâ O; Edsbäcker S
    Br J Clin Pharmacol; 1999 Jun; 47(6):619-24. PubMed ID: 10383539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
    Adjei A; Sundberg D; Miller J; Chun A
    Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of progesterone plasma levels after nasal spray and intramuscular administration of natural progesterone in menopausal women.
    Cicinelli E; Savino F; Cagnazzo I; Scorcia P
    Gynecol Obstet Invest; 1993; 35(3):172-4. PubMed ID: 8505011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioavailability of intranasal lignocaine.
    Scavone JM; Greenblatt DJ; Fraser DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):722-4. PubMed ID: 2611092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.